Inge A. M. van den Oever

610 total citations
7 papers, 479 citations indexed

About

Inge A. M. van den Oever is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, Inge A. M. van den Oever has authored 7 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Rheumatology, 2 papers in Hematology and 2 papers in Immunology. Recurrent topics in Inge A. M. van den Oever's work include Rheumatoid Arthritis Research and Therapies (4 papers), Hepatitis C virus research (2 papers) and Systemic Lupus Erythematosus Research (2 papers). Inge A. M. van den Oever is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (4 papers), Hepatitis C virus research (2 papers) and Systemic Lupus Erythematosus Research (2 papers). Inge A. M. van den Oever collaborates with scholars based in Netherlands, United States and United Kingdom. Inge A. M. van den Oever's co-authors include Michael T. Nurmohamed, Suat Şimşek, Hennie G. Raterman, Naveed Sattar, Alper M. van Sijl, Yvo M. Smulders, Alexandre E. Voskuyl, Ben A. C. Dijkmans, Maarten Boers and Vokko P. van Halm and has published in prestigious journals such as New England Journal of Medicine, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

Inge A. M. van den Oever

7 papers receiving 464 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inge A. M. van den Oever Netherlands 6 137 117 99 78 73 7 479
Ziba Rahimi Iran 16 78 0.6× 114 1.0× 104 1.1× 65 0.8× 61 0.8× 43 582
George Dragicevic Australia 9 114 0.8× 60 0.5× 128 1.3× 87 1.1× 78 1.1× 10 433
Vincenzo Paoletti Italy 14 129 0.9× 77 0.7× 111 1.1× 52 0.7× 37 0.5× 22 473
Channa Zhang China 15 44 0.3× 150 1.3× 192 1.9× 61 0.8× 81 1.1× 38 609
Martin F. Reiner Switzerland 17 43 0.3× 152 1.3× 128 1.3× 71 0.9× 94 1.3× 47 697
Nadya Mothu France 10 44 0.3× 95 0.8× 88 0.9× 55 0.7× 69 0.9× 11 689
Serena Masetti Italy 8 140 1.0× 221 1.9× 108 1.1× 57 0.7× 33 0.5× 8 533
Claudia Huesca‐Gómez Mexico 12 60 0.4× 81 0.7× 58 0.6× 90 1.2× 57 0.8× 38 415
Yukiko Kanetsuna Japan 9 79 0.6× 165 1.4× 49 0.5× 64 0.8× 43 0.6× 28 550
Iwona Żak Poland 16 45 0.3× 133 1.1× 144 1.5× 90 1.2× 104 1.4× 56 593

Countries citing papers authored by Inge A. M. van den Oever

Since Specialization
Citations

This map shows the geographic impact of Inge A. M. van den Oever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge A. M. van den Oever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge A. M. van den Oever more than expected).

Fields of papers citing papers by Inge A. M. van den Oever

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inge A. M. van den Oever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge A. M. van den Oever. The network helps show where Inge A. M. van den Oever may publish in the future.

Co-authorship network of co-authors of Inge A. M. van den Oever

This figure shows the co-authorship network connecting the top 25 collaborators of Inge A. M. van den Oever. A scholar is included among the top collaborators of Inge A. M. van den Oever based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inge A. M. van den Oever. Inge A. M. van den Oever is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Oever, Inge A. M. van den, Suat Şimşek, Hennie G. Raterman, et al.. (2020). The effect of anti-TNF treatment on body composition and insulin resistance in patients with rheumatoid arthritis. Rheumatology International. 41(2). 319–328. 24 indexed citations
2.
Oever, Inge A. M. van den, Maaike Heslinga, E. N. Griep, et al.. (2017). Cardiovascular risk management in rheumatoid arthritis patients still suboptimal: the Implementation of Cardiovascular Risk Management in Rheumatoid Arthritis project. Lara D. Veeken. 56(9). 1472–1478. 30 indexed citations
3.
Oever, Inge A. M. van den, Michael T. Nurmohamed, & W.F. Lems. (2014). Niacin for reduction of cardiovascular risk.. New England Journal of Medicine. 371(20). 1942–1942. 1 indexed citations
4.
Oever, Inge A. M. van den, Naveed Sattar, & Michael T. Nurmohamed. (2014). Thromboembolic and cardiovascular risk in rheumatoid arthritis: role of the haemostatic system. Annals of the Rheumatic Diseases. 73(6). 954–957. 64 indexed citations
5.
Oever, Inge A. M. van den, Alper M. van Sijl, & Michael T. Nurmohamed. (2013). Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion. Therapeutic Advances in Musculoskeletal Disease. 5(4). 166–181. 38 indexed citations
6.
Sijl, Alper M. van, Inge A. M. van den Oever, Matthew Peters, et al.. (2011). Subclinical renal dysfunction is independently associated with cardiovascular events in rheumatoid arthritis: the CARRÉ Study. Annals of the Rheumatic Diseases. 71(3). 341–344. 23 indexed citations
7.
Oever, Inge A. M. van den, Hennie G. Raterman, Michael T. Nurmohamed, & Suat Şimşek. (2010). Endothelial Dysfunction, Inflammation, and Apoptosis in Diabetes Mellitus. Mediators of Inflammation. 2010. 1–15. 299 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026